Tirzepatide 6mg/1ml vial

Tirzepatide 6 mg/mL — 1 mL Vial

Total medication in vial: 6 mg tirzepatide

This 1 mL vial contains compounded tirzepatide at a concentration of 6 mg per mL. This option may be appropriate for patients beginning treatment or receiving lower prescribed doses as part of their individualized weight-management plan.

Tirzepatide is used as part of a medically supervised weight-management program that may include nutrition, physical activity, lifestyle changes, and ongoing clinical monitoring.

Your Phoenix Clinical Services provider will determine your appropriate dose and treatment schedule based on your individual needs, response to treatment, and medication tolerance.

Prescription and medical evaluation required. Follow only the dosing instructions provided specifically for your prescription. Compounded medications are not FDA-approved and may differ from FDA-approved tirzepatide products.